Trobix Innovation
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $6M
Investors
- 1
About Trobix Innovation
Founded in 2018 and based in Netanya, Israel, Trobix Innovation Ltd.Trobix Innovation Ltd. specializes in biotherapeutic development utilizing TBX™ products for in vivo gut production, particularly targeting metabolic and cancer-related health issues.Trobix Bio specializes in the development of TBX™ products designed for in vivo gut production of biotherapeutics, targeting metabolic inflammatory conditions and cancer diseases. Their offerings leverage engineered phages for precise delivery of DNA cargo to target bacteria, facilitating innovative treatments through CRISPR and synthetic biology methodologies. These products are aimed at modifying the microbiome to enhance therapeutic outcomes, addressing issues such as transient colonization and dysbiosis. The company’s core mission is to harness the body’s own microbiome as a means for the sustained secretion of biotherapeutics, thereby ensuring robust efficacy without disrupting the microbiome’s natural composition.Trobix Bio engages in revenue generation through strategic partnerships and direct collaborations with healthcare providers and research institutions. The company’s business model includes agreements where clients may access TBX™ products for clinical applications in treating various diseases, particularly those affecting the microbiome. Transactions typically involve structured partnerships whereby clients secure access to product pipelines, potentially integrating TBX™ solutions into their therapeutic regimens. Pricing structures are based on the specific applications of the TBX™ products, tailored to meet the needs of institutional clients such as hospitals and research facilities.In March 2023, Trobix Innovation Ltd. Trobix plans to introduce new TBX™ products aimed at expanding therapeutic applications and intends to explore growth opportunities in additional markets in North America and Europe by the end of 2024.
Who invested in Trobix Innovation
1 investor across 2 rounds
See all investors in Trobix Innovation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Trobix Innovation
Who invested in Trobix Innovation?
Trobix Innovation has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trobix Innovation raised?
Trobix Innovation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Trobix Innovation last raise money?
Trobix Innovation's most recent round on record is a Series A, in Mar 2023.
What does Trobix Innovation do?
Founded in 2018 and based in Netanya, Israel, Trobix Innovation Ltd.
Where is Trobix Innovation headquartered?
Trobix Innovation is headquartered in Netanya, Israel.
Which VCs invest in companies like Trobix Innovation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Trobix Innovation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Trobix Innovation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.